Amgen (AMGN) PT Raised to $340 at Truist Securities
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $440.34 -0.43%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 19 | New: 18
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 19 | New: 18
Join SI Premium – FREE
Truist Securities analyst Greg Renza raised the price target on Amgen (NASDAQ: AMGN) to $340.00 (from $327.00) while maintaining a Hold rating.
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Williams-Sonoma (WSM) PT Raised to $275 at Jefferies
- MongoDB (MDB) PT Raised to $465 at DA Davidson Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
